Case 4: Recurrent Ovarian Cancer, Platinum-Resistant, BRCA WT

Case 4: I-O Therapy for Platinum-Resistant Recurrent DiseaseПодробнее

Case 4: I-O Therapy for Platinum-Resistant Recurrent Disease

Case 4: Treating Platinum-Resistant Recurrent DiseaseПодробнее

Case 4: Treating Platinum-Resistant Recurrent Disease

Recurrent Ovarian Cancer: Third-Line Therapy and BeyondПодробнее

Recurrent Ovarian Cancer: Third-Line Therapy and Beyond

Considerations for Managing Recurrent Ovarian CancerПодробнее

Considerations for Managing Recurrent Ovarian Cancer

Case-Based Overview: Pretreated Recurrent Ovarian CancerПодробнее

Case-Based Overview: Pretreated Recurrent Ovarian Cancer

Recurrent Ovarian Cancer: QUADRA TrialПодробнее

Recurrent Ovarian Cancer: QUADRA Trial

Emerging opportunities in platinum-resistant recurrent ovarian cancerПодробнее

Emerging opportunities in platinum-resistant recurrent ovarian cancer

Olaparib Maintenance for Recurrent Ovarian CancerПодробнее

Olaparib Maintenance for Recurrent Ovarian Cancer

Case 3: Maintenance Therapy for Recurrent Ovarian CancerПодробнее

Case 3: Maintenance Therapy for Recurrent Ovarian Cancer

Strategies for Managing Recurrent Ovarian CancerПодробнее

Strategies for Managing Recurrent Ovarian Cancer

Relacorilant + nab-paclitaxel in recurrent, platinum-resistant ovarian cancerПодробнее

Relacorilant + nab-paclitaxel in recurrent, platinum-resistant ovarian cancer

Case 3: Second-Line Therapy for Recurrent Ovarian CancerПодробнее

Case 3: Second-Line Therapy for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer: Novel Agents Under InvestigationПодробнее

Recurrent Ovarian Cancer: Novel Agents Under Investigation

Case Study: Platinum Sensitive Recurrent High-Grade Serous Ovarian CancerПодробнее

Case Study: Platinum Sensitive Recurrent High-Grade Serous Ovarian Cancer

Ovarian Cancer: Testing for BRCA MutationsПодробнее

Ovarian Cancer: Testing for BRCA Mutations

Bevacizumab in Platinum-Resistant Ovarian CancerПодробнее

Bevacizumab in Platinum-Resistant Ovarian Cancer

Dr. Arend on Unmet Needs in Platinum-Resistant Ovarian CancerПодробнее

Dr. Arend on Unmet Needs in Platinum-Resistant Ovarian Cancer

Recurrent Advanced Ovarian Cancer: Case ImpressionsПодробнее

Recurrent Advanced Ovarian Cancer: Case Impressions

Case 3: PARP Inhibition in Recurrent Ovarian CancerПодробнее

Case 3: PARP Inhibition in Recurrent Ovarian Cancer

Dr. Matulonis Discusses Niraparib/Pembrolizumab Combo in Platinum-Resistant Ovarian CancerПодробнее

Dr. Matulonis Discusses Niraparib/Pembrolizumab Combo in Platinum-Resistant Ovarian Cancer

События